Opening book details…
About this Medicine article
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02) by Felipe García; Juan Carlos López Bernaldo de Quirós; Carmen E. Gómez; Beatriz Perdiguero; Jose L. Nájera; Victoria Jiménez; Juan García-Arriaza; Alberto C. Guardo; Iñaki Pérez; Vicens Díaz-Brito; Matilde Sánchez Conde; Nuria González; Amparo Alvarez; José Alcamí; José Luis Jiménez; Judit Pich; Joan Albert Arnaiz; María J. Maleno; Agathe León; María Angeles Muñoz-Fernández; Peter Liljeström; Jonathan Weber; Giuseppe Pantaleo; José M. Gatell; Montserrat Plana; Mariano Esteban is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Felipe García; Juan Carlos López Bernaldo de Quirós; Carmen E. Gómez; Beatriz Perdiguero; Jose L. Nájera; Victoria Jiménez; Juan García-Arriaza; Alberto C. Guardo; Iñaki Pérez; Vicens Díaz-Brito; Matilde Sánchez Conde; Nuria González; Amparo Alvarez; José Alcamí; José Luis Jiménez; Judit Pich; Joan Albert Arnaiz; María J. Maleno; Agathe León; María Angeles Muñoz-Fernández; Peter Liljeström; Jonathan Weber; Giuseppe Pantaleo; José M. Gatell; Montserrat Plana; Mariano Esteban
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV; ScienceOpen (ISSN 0264-410X)
- Published
- 2011
- Language
- EN
- Field
- Medicine (Health Sciences)